Clinical and hormonal effects of ethinylestradiol combined with gestodene and desogestrel in young women with acne vulgaris

Contraception

Volumn 53, Issue 3, 1996, Pages 163-170

  Mango, D ^a,b   Ricci, S ^a   Manna, P ^a   Miggiano, G A D ^b   Serra, G B ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b NONE

Author keywords

acne; androgens; desogestrel; gestodene

Indexed keywords

ANDROSTENEDIONE; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; GESTAGEN; GESTODENE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ACNE VULGARIS; ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HORMONAL CONTRACEPTION; HUMAN; MENSTRUAL CYCLE; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

EID: 0029986117     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/0010-7824(96)00005-4     Document Type: Article

References (18)

1. Reingold SB, Rosenfield RL. The relationship of mild hirsutism or acne in women to androgens. Arch Dermatol 1987;123:209-12.
2. Schiavone FE, Rietschel RL, Sgoutas D, Harris R. Elevated free testosterone levels in women with acne. Arch Dermatol 1983;119:799-802.
3. Darley CR, Kirby JD, Besser GM, Munro DD, Edwards CRW, Rees LH. Circulating testosterone, sex hormone binding globulin and prolactin in women with late onset or persistent acne vulgaris. Br J Dermatol 1982;106: 517-22.
4. Carlborg L. Cyproterone acetate versus levonorgestrel combined with ethinyl-estradiol in the treatment of acne. Acta Obstet Gynecol Scand 1986;134(Suppl.):29-32.
5. Olsen TG. Therapy of acne. Med Clin North Am 1982; 66:851-71.
6. Daly L, Bonnar J. Comparative studies of 30 μg ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets. Am J Obstet Gynecol 1990;163:430-7.
7. Gevers Leuven JA, Dersjant-Roorda MC, Helmerhorst FM, Rinse de Boer, Neymeyer-Leloux A, Havekes L. Estrogenic effect of gestodene-or desogestrel-containing oral contraceptives on lipoprotein metabolism. Am J Obstet Gynecol 1990;163:358-62.
8. Ferriman D, Gallway JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21:1440-47.
9. Adams J, Polson DW, Abdulwahid N et al. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 1985;2:1375-8.
10. Pillsbury DM, Shelley WB, Kligman AM, eds. Dermatology. Philadelphia: WB Saunders, 1956:807-10.
11. Badawy SZA, Cittadino R, Marshall L. Testosterone: testosterone-estradiol binding globulin ratio in evaluating hirsute women. Int J Fertil 1982;27:166.
12. Hammond GL, Langley MS, Robinson PA et al. Serum steroid binding protein concentration, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Fertil Steril 1984;42:44-51.
13. Dewis P, Petsos P, Newman M et al. The treatment of hirsutism with a combination of desogestrel and ethinylestradiol. Clin Endocrinol 1985;22:29-36.
14. Cullberg G. Effect of low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 1985;64: 195-202.
15. Nappi C, Farace MJ, Leone F, Minutolo M, Tommaselli AP, Montemagno U. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism. Eur J Obstet Gynecol Reprod Biol 1987;25:209-19.
16. Colver GB, Mortimer PS, Dawber RPR. Cyproterone acetate and two doses of oestrogen in female acne; a double-blind comparison. Br J Dermatol 1988;118:95-9.
17. Lemay A, Dewailly SD, Grenier R, Huard J. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel. J Clin Endocrinol Metab 1990;71:8-14.
18. Hoffman CJ, Kuhl H. Divergent effects of two low-dose oral contraceptives on sex hormone-binding globulin and free testosterone. Am J Obstet Gynecol 1987;156: 199-203.